HLA-DQA1 and melanoma: Planelles and coworkers reported that homozygosis for HLA allele DQA1*05:05, as well as the effect of the double dosage of the DQA1*05:05‐DQB1*03:01 or DQA1*03:01‐DQB1*03:01 heterodimers, may be a potential risk factor for melanoma in the Spanish population (85).